What question did this study set out to answer?

This analysis aims to evaluate the short- and intermediate-term outcomes of CABG in patients with end-stage renal disease.

July 8, 2026Journal of CardioRenal MedicineOpen Access

Beating-Heart Coronary Artery Bypass Grafting in Patients with End-Stage Renal Failure: Short-Term Gains, Intermediate-Term Losses

View Full Paper

Ask AI

Bookmark

Authors

Randomized trial reports short-term gains and long-term losses in end-stage renal disease patients undergoing CABG, indicating persistent risks.

This analysis aims to evaluate the short- and intermediate-term outcomes of CABG in patients with end-stage renal disease.
Data collected from consecutive patients undergoing BH-CABG from January 2019 to May 2025
Preoperative risk assessment performed using the STS Risk Assessment tool
Postoperative outcomes including mortality, morbidity, and length of stay recorded, with ongoing follow-up assessments.
Operative mortality was 1.7%, with overall mortality/morbidity at 5.1%, compared to STS predictions of 5.7% for mortality and 26.8% for combined mortality/morbidity.
Out of 59 ESRD patients, 36 were alive at follow-up, while 23 expired primarily due to cardiac issues and sepsis.
Renal transplantation was performed in 15% of patients, with a 67% survival rate among transplant recipients.

Samuels et al. (2026) studied this question.

View Full Paper

Ask AI

Bookmark

Randomized trial reports short-term gains and long-term losses in end-stage renal disease patients undergoing CABG, indicating persistent risks.